United States, New York — New York, New York

United States, New York is a clinical research site located in New York, New York, United States 10028.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

United States, New York has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Pain, Aging, Includes: Hereditary Angioedema.

Sponsors: Teoxane SA, CSL Behring, UCB Biopharma S.P.R.L..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, New York?

United States, New York has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, New York conducted?

United States, New York has 8 clinical trials on record, with 1 currently active. Their work covers Pain, Aging, Includes: Hereditary Angioedema.

Is United States, New York accredited by Crixeo Health?

Yes — United States, New York holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about United States, New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.